Emerging role of Protein Kinase CK2 in Tumor immunity

Protein kinase CK2, a conserved serine/threonine-protein kinase, is ubiquitous in cells and regulates various intracellular processes, especially in tumor cells. As one of the earliest discovered protein kinases in humans, CK2 plays a crucial role in phosphorylating or associating with hundreds of s...

Full description

Bibliographic Details
Main Authors: Leichong Chen, Sijia Zhang, Qianwen Li, Junyu Li, Huilin Deng, Sheng Zhang, Rui Meng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1065027/full
_version_ 1797987467476860928
author Leichong Chen
Sijia Zhang
Qianwen Li
Junyu Li
Huilin Deng
Sheng Zhang
Rui Meng
author_facet Leichong Chen
Sijia Zhang
Qianwen Li
Junyu Li
Huilin Deng
Sheng Zhang
Rui Meng
author_sort Leichong Chen
collection DOAJ
description Protein kinase CK2, a conserved serine/threonine-protein kinase, is ubiquitous in cells and regulates various intracellular processes, especially in tumor cells. As one of the earliest discovered protein kinases in humans, CK2 plays a crucial role in phosphorylating or associating with hundreds of substrates to modulate several signaling pathways. Excellent reviews have reported that the overexpression of CK2 could be observed in many cancers and was closely associated with tumor occurrence and development. The elevation of CK2 is also an indicator of a poor prognosis. Recently, increasing attention has been paid to the relationship between CK2 and tumor immunity. However, there is no comprehensive description of how CK2 regulates the immune cells in the tumor microenvironment (TME). Also, the underlying mechanisms are still not very clear. In this review, we systematically summarized the correlation between CK2 and tumor immunity, primarily the effects on various immune cells, both in innate and adaptive immunity in the TME. With the comprehensive development of immunotherapy and the mounting transformation research of CK2 inhibitors from the bench to the clinic, this review will provide vital information to find new treatment options for enhancing the efficacy of immunotherapy.
first_indexed 2024-04-11T07:48:57Z
format Article
id doaj.art-fddcedf3c4654d7ca4803898443082fc
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T07:48:57Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-fddcedf3c4654d7ca4803898443082fc2022-12-22T04:36:10ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-12-011210.3389/fonc.2022.10650271065027Emerging role of Protein Kinase CK2 in Tumor immunityLeichong Chen0Sijia Zhang1Qianwen Li2Junyu Li3Huilin Deng4Sheng Zhang5Rui Meng6Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaProtein kinase CK2, a conserved serine/threonine-protein kinase, is ubiquitous in cells and regulates various intracellular processes, especially in tumor cells. As one of the earliest discovered protein kinases in humans, CK2 plays a crucial role in phosphorylating or associating with hundreds of substrates to modulate several signaling pathways. Excellent reviews have reported that the overexpression of CK2 could be observed in many cancers and was closely associated with tumor occurrence and development. The elevation of CK2 is also an indicator of a poor prognosis. Recently, increasing attention has been paid to the relationship between CK2 and tumor immunity. However, there is no comprehensive description of how CK2 regulates the immune cells in the tumor microenvironment (TME). Also, the underlying mechanisms are still not very clear. In this review, we systematically summarized the correlation between CK2 and tumor immunity, primarily the effects on various immune cells, both in innate and adaptive immunity in the TME. With the comprehensive development of immunotherapy and the mounting transformation research of CK2 inhibitors from the bench to the clinic, this review will provide vital information to find new treatment options for enhancing the efficacy of immunotherapy.https://www.frontiersin.org/articles/10.3389/fonc.2022.1065027/fullprotein kinase CK2tumor immunity and immunotherapytumor microenvirenmentPD-L1signal pathway
spellingShingle Leichong Chen
Sijia Zhang
Qianwen Li
Junyu Li
Huilin Deng
Sheng Zhang
Rui Meng
Emerging role of Protein Kinase CK2 in Tumor immunity
Frontiers in Oncology
protein kinase CK2
tumor immunity and immunotherapy
tumor microenvirenment
PD-L1
signal pathway
title Emerging role of Protein Kinase CK2 in Tumor immunity
title_full Emerging role of Protein Kinase CK2 in Tumor immunity
title_fullStr Emerging role of Protein Kinase CK2 in Tumor immunity
title_full_unstemmed Emerging role of Protein Kinase CK2 in Tumor immunity
title_short Emerging role of Protein Kinase CK2 in Tumor immunity
title_sort emerging role of protein kinase ck2 in tumor immunity
topic protein kinase CK2
tumor immunity and immunotherapy
tumor microenvirenment
PD-L1
signal pathway
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1065027/full
work_keys_str_mv AT leichongchen emergingroleofproteinkinaseck2intumorimmunity
AT sijiazhang emergingroleofproteinkinaseck2intumorimmunity
AT qianwenli emergingroleofproteinkinaseck2intumorimmunity
AT junyuli emergingroleofproteinkinaseck2intumorimmunity
AT huilindeng emergingroleofproteinkinaseck2intumorimmunity
AT shengzhang emergingroleofproteinkinaseck2intumorimmunity
AT ruimeng emergingroleofproteinkinaseck2intumorimmunity